Paragraf Acquires Cardea Bio
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
Stay updated with breaking news from Michael Heltzen. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
Paragraf, currently the only company in the world to mass produce graphene electronics using transfer-free graphene and standard semiconductor processes, has acquired Cardea Bio, a producer of graphene-based biocompatible chips. Cardea Bio is to be renamed Paragraf USA.
/PRNewswire/ -- Inc. today announced its sixth annual Female Founders list, honoring a bold group of 200 women whose innovations and ideas are shaping the...
SAN DIEGO, April 4, 2023 /PRNewswire/ -- Inc. today announced its sixth annual Female Founders list, honoring a bold group of 200 women whose inno...
/PRNewswire/ -- Today, at the prestigious Advances in Genome Biology and Technology (AGBT) conference in Orlando Florida, Chief Scientific Officer of Cardea...